|Title||Integrating genomics into clinical oncology: Ethical and social challenges from proponents of personalized medicine|
|Publication Type||Journal Article|
|Year of Publication||2014|
|Authors||McGowan, ML, Settersten, RA, Juengst, ET, Fishman, JR|
|Journal||Urologic Oncology: Seminars and Original Investigations|
|Pagination||187 - 192|
The use of molecular tools to individualize health care, predict appropriate therapies, and prevent adverse health outcomes has gained significant traction in the field of oncology under the banner of “personalized medicine” (PM). Enthusiasm for PM in oncology has been fueled by success stories of targeted treatments for a variety of cancers based on their molecular profiles. Though these are clear indications of optimism for PM, little is known about the ethical and social implications of personalized approaches in clinical oncology.